Gene content    
WWOX ( by HUGO)
WW Domain Containing Oxidoreductase
Tumor suppressor gene
WW Domain Containing Oxidoreductase
FOR
WW Domain-Containing Oxidoreductase
Fragile Site FRA16D Oxidoreductase
WOX1
SCAR12
Member 1
Short Chain Dehydrogenase/Reductase Family 41C
D16S432E
FRA16D
HHCMA56
PRO0128
SDR41C1
Short Chain Dehydrogenase/Reductase Family 41C
Member 1
WW Domain-Containing Protein WWOX
EC 1.1.1.-
EC 1.1.1
NCBI: 16q23.3-q24.1    Ensembl: 16q23.1
WWOX_HUMANSize: 414 amino acidsMass: 46677 Da

  • Subunit: Interacts with TP53, p73/TP73 and MAPK8. Interacts with MAPT/TAU, RUNX2 and HYAL2 (By similarity). Forms a ternary complex with TP53 and MDM2. Interacts with ERBB4, LITAF and WBP1. Interacts with DVL1, DVL2 and DVL3. May interact with FAM189B and SCOTIN. Interacts with TNK2. Interacts with TMEM207 Sequence caution: Sequence=AAP94227.1; Type=Frameshift; Positions=362; 1 PDB 3D structure from [IMAGE] and Proteopedia [IMAGE] for WWOX: 1WMV (3D) [IMAGE]
  • Tissue specificity: Widely expressed. Strongly expressed in testis, prostate, and ovary. Overexpressed in cancer cell lines. Isoform 5 and isoform 6 may only be expressed in tumor cell lines [IMAGE] Pathway & Disease-focused RT2 Profiler PCR Array including WWOX: Oncogenes &
  • Function:
    UniProtKB/Swiss-Prot Summary: WWOX_HUMAN, Q9NZC7 Function: Putative oxidoreductase. Acts as a tumor suppressor and plays a role in apoptosis. Required for normal bone development (By similarity). May function synergistically with p53/TP53 to control genotoxic stress-induced cell death. Plays a role in TGFB1 signaling and TGFB1-mediated cell death. May also play a role in tumor necrosis factor (TNF)-mediated cell death. Inhibits Wnt signaling, probably by sequestering DVL2 in the cytoplasm Enzyme Numbers (IUBMB): EC 1.1.12 EC 1.1.1.-1 Gene Ontology (GO): Selected molecular function terms (see all 6): About this table GO ID Qualified GO term Evidence PubMed IDs GO:0005515 protein binding IPI 15064722 GO:0016491 oxidoreductase activity TAS 10786676 GO:0019899 enzyme binding IPI 19366691 GO:0046983 protein dimerization activity TAS 10786676 GO:0048037 cofactor binding TAS 10786676 [IMAGE] Find genes that share ontologies with WWOX About GenesLikeMe Phenotypes: 5 GenomeRNAi human phenotypes for WWOX: Decreased viability with cispl Increased cell death HMECs cel Increased cell death in breast Increased cilium length after Increased gamma-H2AX phosphory
  • Similarity:
    Belongs to the short-chain dehydrogenases/reductases (SDR) family
                          
    Contains 2 WW domains [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR001202WW_domWW/Rsp5/WWPDomain
    IPR002198DH_sc/Rdtase_SDRShort-chain dehydrogenase/reductase SDRFamily
    IPR002347Glc/ribitol_DHGlucose/ribitol dehydrogenaseFamily
    BlocksIPB002198Short-chain dehydrogenase/reductase SDRShort-chain dehydrogenase/reductase SDR
    IPB002347Glucose/ribitol dehydrogenase family signatureGlucose/ribitol dehydrogenase family signature

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process cellular response to transforming growth factor beta stimulus IDA GOA 19366691
    negative regulation of Wnt signaling pathway IDA GOA 19465938
    oxidation-reduction process TAS GOA 10786676
    steroid metabolic process TAS GOA 10786676
    Cellular Component colocalizes_with microvillus IDA GOA 19366691
    colocalizes_with plasma membrane IDA GOA 19366691
    cytoplasm TAS GOA 10786676
    cytoplasm IDA GOA 19465938
    cytosol IDA GOA 19366691
    Golgi apparatus IDA GOA 15064722
    nucleus IDA GOA 19366691
    Molecular Function coenzyme binding TAS GOA 10786676
    cofactor binding TAS GOA 10786676
    enzyme binding IPI GOA 19366691
    oxidoreductase activity TAS GOA 10786676
    oxidoreductase activity NAS GOA 10861292
    protein binding IPI GOA 15064722
    protein dimerization activity TAS GOA 10786676

    Disorder & Mutation    
    Source Disease
    SWISS-PROTNote=Defects in WWOX may be involved in several cancer types. The gene spans the second most common chromosomal fragile site (FRA16D) which is frequently altered in cancers. Alteration of the expression and expression of some isoforms is associated with cancers. However, it is still unclear if alteration of WWOX is directly implicated in cancerogenesis or if it corresponds to a secondary effect
    SWISS-PROTEsophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. Note=The disease may be caused by mutations affecting the gene represented in this entry

    WWOX cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene